HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Seung Joon Baek Selected Research

tolfenamic acid

6/2016Tolfenamic acid downregulates β-catenin in colon cancer.
5/2014Anti-tumor activity of non-steroidal anti-inflammatory drugs: cyclooxygenase-independent targets.
2/2014Tolfenamic acid induces apoptosis and growth inhibition in anaplastic thyroid cancer: Involvement of nonsteroidal anti-inflammatory drug-activated gene-1 expression and intracellular reactive oxygen species generation.
12/2013The involvement of endoplasmic reticulum stress in the suppression of colorectal tumorigenesis by tolfenamic acid.
10/2013A mechanistic study of the proapoptotic effect of tolfenamic acid: involvement of NF-κB activation.
9/2013Reactive oxygen species mediate tolfenamic acid-induced apoptosis in human colorectal cancer cells.
1/2012Tolfenamic acid induces apoptosis and growth inhibition in head and neck cancer: involvement of NAG-1 expression.
12/2008ESE-1/EGR-1 pathway plays a role in tolfenamic acid-induced apoptosis in colorectal cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Seung Joon Baek Research Topics

Disease

64Neoplasms (Cancer)
01/2022 - 05/2002
33Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 06/2002
20Carcinogenesis
08/2014 - 11/2004
8Inflammation (Inflammations)
01/2022 - 10/2005
6Colonic Neoplasms (Colon Cancer)
06/2016 - 02/2003
5Breast Neoplasms (Breast Cancer)
10/2021 - 09/2007
4Osteosarcoma (Osteogenic Sarcoma)
06/2020 - 01/2008
4Neoplasm Metastasis (Metastasis)
09/2018 - 06/2008
4Head and Neck Neoplasms (Head and Neck Cancer)
11/2016 - 01/2012
3Prostatic Neoplasms (Prostate Cancer)
02/2014 - 09/2006
3Lung Neoplasms (Lung Cancer)
04/2010 - 09/2008
2Body Weight (Weight, Body)
01/2021 - 06/2016
2Hyperglycemia
08/2020 - 09/2013
2Adenocarcinoma
04/2018 - 05/2009
2Polyps
12/2013 - 12/2010
2Ataxia Telangiectasia (Louis Bar Syndrome)
06/2013 - 12/2010
2Squamous Cell Carcinoma of Head and Neck
06/2013 - 12/2006
2Pancreatic Neoplasms (Pancreatic Cancer)
09/2012 - 12/2008
2Chronic Disease (Chronic Diseases)
08/2012 - 01/2004
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022
1Neuroinflammatory Diseases
01/2022
1Weight Loss (Weight Reduction)
08/2020
1Non-alcoholic Fatty Liver Disease
08/2020
1Metabolic Diseases (Metabolic Disease)
01/2019
1Obesity
01/2019

Drug/Important Bio-Agent (IBA)

23Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2019 - 05/2002
20Proteins (Proteins, Gene)FDA Link
01/2019 - 05/2002
17Pharmaceutical PreparationsIBA
02/2014 - 03/2003
9PPAR gammaIBA
09/2012 - 02/2003
8tolfenamic acidIBA
06/2016 - 12/2008
8LigandsIBA
09/2013 - 02/2003
7Cyclin D1IBA
05/2016 - 01/2006
7TeaIBA
06/2013 - 12/2006
6Chalcone (Benzalacetophenone)IBA
10/2021 - 10/2016
6Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
05/2014 - 10/2005
6netoglitazoneIBA
09/2013 - 05/2006
5Peroxisome Proliferator-Activated Receptors (PPAR)IBA
09/2013 - 12/2005
4Biological ProductsIBA
10/2021 - 10/2005
4ChalconesIBA
10/2021 - 10/2016
4damnacanthalIBA
12/2018 - 12/2011
4sulindac sulfideIBA
05/2014 - 03/2005
4Transforming Growth Factor beta (TGF-beta)IBA
03/2013 - 12/2004
3Small Interfering RNA (siRNA)IBA
10/2021 - 12/2008
33,3'-diindolylmethane (diindolylmethane)IBA
07/2017 - 03/2005
3CateninsIBA
11/2016 - 06/2012
3AzoxymethaneIBA
09/2013 - 11/2006
3Transcription Factors (Transcription Factor)IBA
01/2012 - 04/2008
3ProstaglandinsIBA
12/2011 - 01/2006
3Phosphotransferases (Kinase)IBA
12/2010 - 12/2005
3Apoptosis Regulatory ProteinsIBA
12/2010 - 01/2010
3Glycogen Synthase Kinase 3 betaIBA
04/2010 - 11/2004
2ApigeninIBA
01/2022 - 12/2010
2PhytochemicalsIBA
01/2022 - 10/2021
2CytokinesIBA
01/2022 - 04/2010
2AntioxidantsIBA
10/2021 - 09/2020
21,1- bis(3'- indolyl)- 1- (4- t- butylphenyl)methaneIBA
01/2021 - 12/2005
2Growth Differentiation Factor 15IBA
01/2019 - 08/2006
2licochalcone AIBA
08/2018 - 01/2017
2indole-3-carbinolIBA
07/2017 - 03/2005
2Glycoproteins (Glycoprotein)IBA
01/2017 - 08/2014
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2016 - 06/2008
2ZyflamendIBA
02/2014 - 11/2011
2Reactive Oxygen Species (Oxygen Radicals)IBA
02/2014 - 09/2013
2epigallocatechin gallate (epigallocatechin-3-gallate)IBA
06/2013 - 12/2012
2Activating Transcription Factor 3IBA
04/2013 - 01/2011
2Biomarkers (Surrogate Marker)IBA
03/2013 - 07/2010
2Capsaicin (Zostrix)FDA Link
06/2012 - 04/2010
2ResveratrolIBA
01/2012 - 01/2011
2CarcinogensIBA
01/2012 - 11/2006
2Arachidonic Acid (Vitamin F)IBA
12/2011 - 05/2009
22,4-thiazolidinedione (thiazolidinedione)IBA
07/2010 - 05/2006
2Messenger RNA (mRNA)IBA
07/2010 - 03/2003
2AgarIBA
12/2009 - 09/2006
2Cyclooxygenase InhibitorsIBA
12/2009 - 12/2004
2PolyphenolsIBA
08/2008 - 10/2005
2beta CateninIBA
03/2008 - 01/2006
2epicatechin gallateIBA
12/2006 - 12/2004
2Troglitazone (Rezulin)FDA Link
02/2004 - 02/2003
1Whey ProteinsIBA
01/2022
1bisphenol AIBA
01/2022
1Ergosterol (Lumisterol)IBA
01/2022
1HexanesIBA
01/2022
1Ethanol (Ethyl Alcohol)IBA
01/2022
1Heme Oxygenase-1IBA
10/2021
1Therapeutic UsesIBA
10/2021
1Insulin (Novolin)FDA Link
01/2021
1Blood Glucose (Blood Sugar)IBA
01/2021
1nootkatoneIBA
09/2020
1Antimutagenic Agents (Antimutagens)IBA
08/2020
1Nuclear Localization Signals (Nuclear Localization Signal)IBA
10/2019
1HMGB1 Protein (HMG1)IBA
05/2019
1Aurora Kinase AIBA
08/2018
1Polysaccharides (Glycans)IBA
04/2018
1CurcuminIBA
04/2018
1Tumor Suppressor Protein p53IBA
01/2018
1Peptide Hydrolases (Proteases)FDA Link
07/2017

Therapy/Procedure

9Therapeutics
05/2019 - 11/2004
4Chemoprevention
05/2016 - 05/2002
1Radiotherapy
06/2020
1Heart Transplantation (Grafting, Heart)
05/2017